Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Ullrich

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2004
Detection of ERK1/2 activities using affinity reagentsRafael Pulido, Angel Zúñiga, Axel Ullrich
Breast Care (Basel, Switzerland)|September 9, 2010
Development of Targeted Therapies in ErbB2-Positive Breast CancerChristian Jackisch, Josef Rüschoff, Axel Ullrich
Oncogene|December 3, 2003
Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasionBeatrix Schäfer, Andreas Gschwind, Axel Ullrich
The Journal of Biological Chemistry|February 21, 2003
Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitorsStephanie Blencke, Axel Ullrich, Henrik Daub
Biological Chemistry|September 17, 2003
EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2Yingjie Wu, Zhengjun Chen, Axel Ullrich
Nature Reviews. Drug Discovery|December 2, 2004
Strategies to overcome resistance to targeted protein kinase inhibitorsHenrik Daub, Katja Specht, Axel Ullrich
Cancer Research|November 5, 2002
Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivationAndreas Gschwind, Norbert Prenzel, Axel Ullrich
Thescientificworldjournal|August 28, 2018
Identification of Antiapoptotic Protein Kinases and Phosphatases by a Functional Genomics ApproachReimar Abraham, Daniel Schubart, Axel Ullrich
The Journal of Biological Chemistry|December 9, 2003
Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1Miriam Gensler, Marcus Buschbeck, Axel Ullrich
Molecular Oncology|July 5, 2017
GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistanceChristine Baumann, Axel Ullrich, Robert Torka
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2004
Detection of ERK1/2 activities using affinity reagentsRafael Pulido, Angel Zúñiga, Axel Ullrich
Breast Care (Basel, Switzerland)|September 9, 2010
Development of Targeted Therapies in ErbB2-Positive Breast CancerChristian Jackisch, Josef Rüschoff, Axel Ullrich
Oncogene|December 3, 2003
Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasionBeatrix Schäfer, Andreas Gschwind, Axel Ullrich
The Journal of Biological Chemistry|February 21, 2003
Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitorsStephanie Blencke, Axel Ullrich, Henrik Daub
Biological Chemistry|September 17, 2003
EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2Yingjie Wu, Zhengjun Chen, Axel Ullrich
Nature Reviews. Drug Discovery|December 2, 2004
Strategies to overcome resistance to targeted protein kinase inhibitorsHenrik Daub, Katja Specht, Axel Ullrich
Cancer Research|November 5, 2002
Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivationAndreas Gschwind, Norbert Prenzel, Axel Ullrich
Thescientificworldjournal|August 28, 2018
Identification of Antiapoptotic Protein Kinases and Phosphatases by a Functional Genomics ApproachReimar Abraham, Daniel Schubart, Axel Ullrich
The Journal of Biological Chemistry|December 9, 2003
Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1Miriam Gensler, Marcus Buschbeck, Axel Ullrich
Molecular Oncology|July 5, 2017
GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistanceChristine Baumann, Axel Ullrich, Robert Torka
Pageof 13